CONTENTS:
- Responding to 100?000 annual drug overdose deaths in the United States: a special section of commentaries [Editorial]. Humphreys K., Marsden J., p. 1187.
- What lessons from Estonia's experience could be applied in the United States in response to the addiction and overdose crisis? Abel-Ollo K., p. 1188-1189.
- What lessons from Sweden's experience could be applied in the United States in response to the addiction and overdose crisis? Fugelstad A., p. 1189-1191.
- What lessons from France's experience could be applied in the United States in response to the addiction and overdose crisis? Bergeron H., Colson R., p. 1191-1192.
- What lessons from Norway's experience could be applied in the United States in response to the addiction and overdose crisis? Clausen T., p. 1192-1194.
- Addressing the overdose crisis in North America with bold action. Kolla G., Touesnard N., Gomes T., p. 1194-1196.
- What lessons from Europe's experience could be applied in the United States in response to the opioid addiction and overdose crisis? van den Brink W., Pierce M., van Amsterdam J., p. 1197-1198.
- What policies the US Food and Drug Administration should pursue in response to the addiction and overdose crisis. Frank R.G., p. 1198-1199.
- Exponential growth of drug overdose poisoning and opportunities for intervention. Jalal H., Burke D.S., p. 1200-1202.
- Synthesizing advice to the United States from other nations that have experienced drug epidemics. Humphreys K., Marsden J., p. 1202-1203.
- Declining drinking among adolescents: Are we seeing a denormalisation of drinking and a normalisation of non-drinking? [Addiction opinion and debate]. Caluzzi G., Livingston M., Holmes J., MacLean S., Lubman D., Dietze P., et al., p. 1204-1212.
- The global nature of declining adolescent drinking. Alasuutari P., p. 1213-1214.
- Normalization of non-drinking and implications for alcohol epidemiology. Rossow I., p. 1214-1215.
- Young people's alcohol use is still strongly related to social inclusion. Herold M.D., Kolind T., p. 1216-1217.
- Response to commentaries: (de)normalization of drinking and its implications for young people, sociality, culture and epidemiology. Caluzzi G., Livingston M., Holmes J., MacLean S., Lubman D.I., Dietze P., et al., p. 1217-1219.
- Technology-mediated just-in-time adaptive interventions (JITAIs) to reduce harmful substance use: a systematic review. Perski O., Hébert E.T., Naughton F., Hekler E.B., Brown J., Businelle M.S., p. 1220-1241.
- Reducing craving and consumption in individuals with drug addiction, obesity or overeating through neuromodulation intervention: a systematic review and meta-analysis of its follow-up effects. Song S., Zilverstand A., Gui W., Pan X., Zhou X., p. 1242-1255.
- Commentary on Song et al: Brain stimulation for addictions- optimizing impact via strategic interleaving with pharmacotherapy, cognitive behavioral therapy, and restructuring the micro-environment. Hall P.A., Burhan A.M., p. 1256-1257.
- Youth use of e-liquid flavours - A systematic review exploring patterns of use of e-liquid flavours and associations with continued vaping, tobacco smoking uptake or cessation. Notley C., Gentry S., Cox S., Dockrell M., Havill M., Attwood A.S., et al., p. 1258-1272.
- Tracking the decline in Australian adolescent drinking into adulthood. Livingston M., Callinan S., Vashishtha R., Yuen W.S., Dietze P., p. 1273-1281.
- Commentary on Livingston et al.: Do reductions in adolescent drinking really maintain into adulthood? Kraus L., Olderbak S., p. 1282-1283.
- Momentary associations between stress and alcohol craving in the naturalistic environment: differential associations for Black and White young adults. Pedersen S.L., Kennedy T.M., Holmes J., Molina B.S.G., p. 1284-1294.
- Declines in alcohol consumption in Australia: some challenges to the theory of collectivity. Mojica-Perez Y., Callinan S., Livingston M., p. 1295-1303.
- Longer-term impacts of trading restrictions on alcohol-related violence: insights from New South Wales, Australia. Athanasopoulos G., Sarafidis V., Weatherburn D., Miller R., p. 1304-1311.
- Brain structural covariance network differences in adults with alcohol dependence and heavy-drinking adolescents. Ottino-Gonzalez J., Garavan H., p. 1312-1325.
- Efficacy and comparative effectiveness of telephone and smartphone remote continuing care interventions for alcohol use disorder: a randomized controlled trial. McKay J.R., Gustafson D.H., Ivey M., Pe-Romashko K., Curtis B., Thomas T., et al., p. 1326-1337.
- Modeling the population-level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia. Chaillon A., Bharat C., Stone J., Jones N., Degenhardt L., Larney S., et al., p. 1338-1352.
- Opioid agonist treatment uptake within provincial correctional facilities in British Columbia, Canada. Kurz M., Dale L.M., Min J.E., Hongdilokkul N., Greiner L., Olley M., et al., p. 1353-1362.
- Opioid overdose deaths and the expansion of opioid agonist treatment: a population-based prospective cohort study. Rogeberg O., Bergsvik D., Clausen T., p. 1363-1371.
- Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island. Nolen S., Zang X., Chatterjee A., Behrends C.N., Green T.C., Kumar A., et al., p. 1372-1381.
- Genetic liability for prescription opioid use and risk of cardiovascular diseases: a multivariable Mendelian randomization study. Cai J., He L., Wang H., Rong X., Chen M., Shen Q., et al., p. 1382-1391.
- Understanding long-term trends in smoking in England, 1972-2019: an age-period-cohort approach. Opazo Breton M., Gillespie D., Pryce R., Bogdanovica I., Angus C., Hernandez Alava M., et al., p. 1392-1403.
- Commentary on Opazo Breton et al.: Are declines in smoking prevalence primarily driven by lower initiation of smoking or increases in quitting? Beard E., p. 1404-1405.
- The Stop-tabac smartphone application for smoking cessation: a randomized controlled trial. Etter J.F., Khazaal Y., p. 1406-1415.
- Understanding contexts of smoking and vaping among dual users: analysis of ecological momentary assessment data. Piper M.E., Baker T.B., Zwaga D., Bolt D.M., Kobinsky K.H., Jorenby D.E., p. 1416-1426.
- The old and familiar meets the new and unknown: patient and clinician perceptions on e-cigarettes for smoking reduction in UK general practice, a qualitative interview study. Albury C., Barnes R., Ferrey A., Coleman T., Gilbert H., Naughton F., et al., p. 1427-1437.
- Communication of personalised disease risk by general practitioners to motivate smoking cessation in England: a cost-effectiveness and research prioritisation study. Adamson A., Portas L., Accordini S., Marcon A., Jarvis D., Baio G., et al., p. 1438-1449.
- The geography of sobriety checkpoints and alcohol-impaired driving. Morrison C.N., Kwizera M., Chen Q., Puljevic C., Branas C.C., Wiebe D.J., et al., p. 1450-1457.
- Prenatal smoking, alcohol and caffeine exposure and maternal-reported attention deficit hyperactivity disorder symptoms in childhood: triangulation of evidence using negative control and polygenic risk score analyses. Haan E., Sallis H.M., Zuccolo L., Labrecque J., Ystrom E., Reichborn-Kjennerud T., et al., p. 1458-1471.
- Clinical management of withdrawal from benzodiazepine anxiolytic and hypnotic medications. Baldwin D.S., p. 1472-1482.
- Using death scene and toxicology evidence to define involvement of heroin, pharmaceutical morphine, illicitly manufactured fentanyl and pharmaceutical fentanyl in opioid overdose deaths, 38 states and the District of Columbia, January 2018-December 2019. O'Donnell J., Gladden R.M., Kariisa M., Mattson C.L., p. 1483-1490.
- Addiction Lives: Jacek Moskalewicz. 1491-1492.
- Waterpipe tobacco smoking and oral health: what is important to know? Alves M.G.O., Carvalho B., Marques S.S., Lopes M.A., Almeida J.D., p. 1493-1494.
- Commentary on Lin et al.: The importance of valid reference standards in training supervised machine learning classifiers to detect alcohol misuse. Fitzgerald N.D., Barenholtz E., p. 1494-1495.
- Response to Fitzgerald & Barenholtz: There is still much work to be done for digital classifiers. Karnik N.S., Thompson H.M., Afshar M., p. 1496.